Boardroom Alpha
10-K primary document
NOVT · Annual Report (Form 10-K) · Filed February 23, 2026

Novanta Inc10-K exhibit

novt-ex21_1.htm
EX-21.1

Exhibit 21.1

NOVANTA INC. SUBSIDIARIES

Subsidiary

Place of Incorporation

Novanta Corporation

Michigan

Novanta Japan Corporation

Japan

Novanta Singapore Pte. Ltd.

Singapore

Novanta Technologies UK Limited

United Kingdom

Novanta UK Investments Holding Limited

United Kingdom

Novanta Technologies (Suzhou) Co., Ltd.

China

GSI Lumonics Asia Pacific Ltd.

Hong Kong

Novanta Europe GmbH

Germany

Novanta Distribution (USD) GmbH

Germany

Novanta Italy SRL

Italy

NDS Surgical Imaging, LLC

Delaware

Novanta Holdings BV

Netherlands

Novanta Česká republika s.r.o.

Czech Republic

Laser Quantum Limited

United Kingdom

Novanta Medical GmbH

Germany

Novanta Medical USA, Inc..

Florida

Zettlex (UK) Limited

United Kingdom

Novanta Technologies Spain, S.L..

Spain

Novanta Medical Technologies Corp.

Delaware

ATI Industrial Automation, Inc.

North Carolina

ATI Industrial Mexico, LLC

North Carolina

Novanta Insurance Company

Arizona

ATI Automatizacion Industrial S de RL de CV.

Mexico

ATI Industrial Automation (Lang Fang) Co., Ltd.

China

Novanta Medical s.r.o.

 

Czech Republic

Bearing Engineers, Inc. d/b/a Motion Solutions

 

California

Motion Solutions Parent Corp

 

Delaware

iBex Motion, LLC

 

California

nPoint, Inc.

 

Wisconsin

Novanta Precision Medicine Corporation

 

Delaware

Keonn Technologies, S.L.

 

Spain

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer